Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Ultragenyx Pharmaceutical (RARE) Q2 2024 Earnings
RARE
+1.06%
2
May
Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-2.25
-2.01
-1.76
-1.52
Details
Expected EPS
-1.747161
Actual EPS
-2.03
Surprise EPS
-0.28
Surprise Percent
+16.19%
Description
Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.03 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login